Drugs / BMS-791826
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03198013 | Nov 2008 → May 2009 | — | Bristol-Myers Squibb | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BMS-791826 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03198013 ↗ |
| Modality | Small molecule | — CHEMBL1911274 ↗ |
| Route | Oral | “Placebo-Controlled, Double-Blind, Ascending Single and Multiple Oral Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BMS-791826 and to Assess Its...” NCT03198013 ↗ |